Who
Michael Vincent Meluzio
VP, Prin. Accounting Officer
Company insider
Files Form 4 as: VP, Prin. Accounting Officer, Cue Biopharma.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $371K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jul 2026
- Last trade
- 12 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 14 Oct 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $32K1,144 at $28.05 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code M | —13,647 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $45K1,519 at $29.37 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $125K4,106 at $30.35 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,647 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $933 at $31.13 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,647 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code M | —13,647 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $45K1,519 at $29.37 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $125K4,106 at $30.35 | filing |
| 13 Aug 2026filed 17 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $933 at $31.13 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —40,942 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,942 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,942 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —40,942 at $0.00 | filing |
News
Cue Biopharma (NASDAQ:CUE) VP Michael Vincent Meluzio Sells 1,144 Shares of Stocktickerreport.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 Sharesdailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 SharesCUE · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in StockCUE · themarketsdaily.com · 15 Oct 2026
2 headlines in the last 90 days name Michael Vincent Meluzio; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.